Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:301838rdf:typepubmed:Citationlld:pubmed
pubmed-article:301838lifeskim:mentionsumls-concept:C0341628lld:lifeskim
pubmed-article:301838lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:301838lifeskim:mentionsumls-concept:C0042134lld:lifeskim
pubmed-article:301838lifeskim:mentionsumls-concept:C0033554lld:lifeskim
pubmed-article:301838lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:301838pubmed:issue6lld:pubmed
pubmed-article:301838pubmed:dateCreated1977-9-22lld:pubmed
pubmed-article:301838pubmed:abstractTextThe paper reports on intravenous and intrauterine application of Prostaglandin F2alpha and its 15-methyl derivative for the treatment of severe uterine bleedings in obsteterics and gynaecology. The effectiveness of the compounds is demonstrated.lld:pubmed
pubmed-article:301838pubmed:languagegerlld:pubmed
pubmed-article:301838pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:301838pubmed:citationSubsetIMlld:pubmed
pubmed-article:301838pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:301838pubmed:statusMEDLINElld:pubmed
pubmed-article:301838pubmed:monthJunlld:pubmed
pubmed-article:301838pubmed:issn0016-5751lld:pubmed
pubmed-article:301838pubmed:authorpubmed-author:SteinerHHlld:pubmed
pubmed-article:301838pubmed:authorpubmed-author:ArdeltWWlld:pubmed
pubmed-article:301838pubmed:authorpubmed-author:HillemannsH...lld:pubmed
pubmed-article:301838pubmed:authorpubmed-author:ZahradnikH...lld:pubmed
pubmed-article:301838pubmed:authorpubmed-author:BreckwoldtMMlld:pubmed
pubmed-article:301838pubmed:issnTypePrintlld:pubmed
pubmed-article:301838pubmed:volume37lld:pubmed
pubmed-article:301838pubmed:ownerNLMlld:pubmed
pubmed-article:301838pubmed:authorsCompleteYlld:pubmed
pubmed-article:301838pubmed:pagination493-5lld:pubmed
pubmed-article:301838pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:301838pubmed:meshHeadingpubmed-meshheading:301838-H...lld:pubmed
pubmed-article:301838pubmed:meshHeadingpubmed-meshheading:301838-P...lld:pubmed
pubmed-article:301838pubmed:meshHeadingpubmed-meshheading:301838-A...lld:pubmed
pubmed-article:301838pubmed:meshHeadingpubmed-meshheading:301838-O...lld:pubmed
pubmed-article:301838pubmed:meshHeadingpubmed-meshheading:301838-I...lld:pubmed
pubmed-article:301838pubmed:meshHeadingpubmed-meshheading:301838-F...lld:pubmed
pubmed-article:301838pubmed:meshHeadingpubmed-meshheading:301838-A...lld:pubmed
pubmed-article:301838pubmed:meshHeadingpubmed-meshheading:301838-P...lld:pubmed
pubmed-article:301838pubmed:meshHeadingpubmed-meshheading:301838-A...lld:pubmed
pubmed-article:301838pubmed:meshHeadingpubmed-meshheading:301838-P...lld:pubmed
pubmed-article:301838pubmed:meshHeadingpubmed-meshheading:301838-D...lld:pubmed
pubmed-article:301838pubmed:year1977lld:pubmed
pubmed-article:301838pubmed:articleTitle[Prostaglandin F2alpha- and 15-methyl-prostaglandin F2alpha-application for the treatment of severe uterine bleedings (author's transl)].lld:pubmed
pubmed-article:301838pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:301838pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:301838pubmed:publicationTypeCase Reportslld:pubmed